WHO approves emergency use of 'Covaxin'

Daily Current Affairs / WHO approves emergency use of 'Covaxin'

Change Language English Hindi

Category : National Published on: November 05 2021

Share on facebook

Bharat Biotech's Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above.
This marks a major victory for India's journey in vaccination against Covid-19.
Covaxin is a vaccine, completely 'made in India', by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....

WHO approves emergency use of 'Covaxin'